|

Anti-BCMA-GPRC5D CAR-T cells infusion Clinical Trials

1 actively recruiting trial

Top Sponsors

  • 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China1

Indications

  • Relapsed/ Refractory Multiple Myeloma1
  • Cancer1

Other1 trial

Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.